Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars in healthcare costs each year. Thrombus—the formation of blot clots—is the most…
How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF. TIF will allow us to invest in technologies at an earlier stage within our system and drive…
Last week, Anne Klibanski, MD, CEO of Partners Healthcare, was named one of “The Top 25 Women in Healthcare” by Modern Healthcare. Dr. Klibanski, who has been my mentor since I started my endocrine fellowship in…
Approximately 65 million people suffer from chronic obstructive pulmonary disease (COPD) worldwide, and three million people die from it each year. It is the third leading cause of disease-related death in the U.S. and a significant…
The Partners Innovation Fund (PIF) continues to add to their success in moving therapeutic strategies developed within the Partners HealthCare System (PHS) further down the development pipeline. Several recent deals and series A financing rounds support…
Cardiovascular diseases remain the leading cause of death worldwide and rising expense, making this area ripe for AI-enabled innovations. This AI Update includes discussions from the 2019 World Medical Innovation Forum, an interview from Licensing Manager…
Recent Posts by Category
Cardiovascular diseases remain the leading cause of death worldwide and rising expense, making this area ripe for AI-enabled innovations. This AI Update includes discussions…
$80M Investment to Speed Discovery from Lab to Patient, Fuel Life Sciences Economy Partners HealthCare has announced the creation of two new investment funds…
The Partners Innovation Fellows Program provides up-and-coming faculty/staff physicians and investigators from Partners with an opportunity to work with an industry partner on an…
Historically, scientists have thought of cancer cells as a clone army—since they are all genetically identical, they are universally bad actors. “What we’ve learned…
To read the full interview, click here.
Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars…
In the short time since the emergence of CRISPR gene editing technology, Keith Joung, MD, PhD has been impressed with all the research applications…
The Partners Innovation Fund (PIF) continues to add to their success in moving therapeutic strategies developed within the Partners HealthCare System (PHS) further down…
How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF. TIF will allow us to…
Medical Imaging, Mental Health, Suicide Prevention Make the List of Coming Applications Partners HealthCare today announced its selections for the fifth annual “Disruptive Dozen,”…
Partners HealthCare Creates New Investment Funds to Accelerate Innovation in Medicine
$80M Investment to Speed Discovery from Lab to Patient, Fuel Life Sciences Economy Partners HealthCare has announced the creation of two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences, Artificial Intelligence (AI) and digital technology development. The funds will support ventures that develop…
Read MoreNew “Staff Accelerator” Program Emphasizes Life-Long Learning and Commercialization Excellence
Developing people and keeping pace with the rapidly changing world of healthcare innovation is at the heart of a new “Staff Accelerator” (SA) pilot program just launched at Partners HealthCare Innovation. Combining mentoring programs, developmental opportunities and career and skills development workshops, the SA program is just one part of…
Read MorePfizer Centers for Therapeutic Innovation: Fall 2018 Call-for-Proposals due November 2nd 2018
We are pleased to alert you to the call for proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics. CTI supports translational programs in oncology, autoimmunity & inflammation, metabolic and rare diseases. Deadline to submit to Innovation: Friday, November 2nd 2018 How to apply: Please use…
Read More2019 Partners Innovation Discovery Grant Program: REQUEST FOR APPLICATIONS
We are delighted to announce the fourth round of the Innovation Discovery Grants Program (IDG). Partners HealthCare has renewed this grant program to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate the creation of new products from the innovations of all Partners employees and faculty.…
Read MoreInnovators Honored at 2nd Annual Dinner
The Innovator’s Dinner was held Wednesday evening, April 25th as the concluding event of the 2018 World Medical Innovation Forum. This invitation-only dinner honored the 660 MGH, BWH, McLean and Spaulding principal investigators who submitted an invention disclosure during the calendar year 2017. Each investigator was recognized with a framed…
Read More2018 World Medical Innovation Forum Recap
Thank you to our sell-out crowd of 1,700 registrants, the 169 speakers and our 19 sponsors. The 2018 Forum focused on the advancements and opportunities in Artificial Intelligence. Click here to read full recap!
Read MorePrinted from https://innovationblog.partners.org/blog · Published 12 Feb 2020
© PARTNERS HEALTHCARE. ALL RIGHTS RESERVED
Subscribe
Never miss a post! Sign up to get new blog updates delivered to your email.
Connect